The On-Off chiral mesoporous silica nanoparticles for delivering achiral drug in chiral environment
Source abstract
Abstract
In the current stage, the On-Off mechanism of chiral mesoporous silica nanoparticles (CMSN) for delivering achiral drug in chiral environment has rarely been reported. Herein, On-Off chiral mesoporous silica nanoparticles (On-Off-D-CMSN and On-Off-L-CMSN) were successfully synthesized and its particular contribution in delivering achiral drug indometacin (IMC) in chiral environment was mainly studied. The as-synthesized On-Off-D-CMSN and On-Off-L-CMSN were verified by fourier transform infrared spectrometer and circular dichroism. The transmission electron microscope test and nitrogen adsorption/desorption analysis showed that On-Off-D-CMSN and On-Off-L-CMSN were regular spheres with concealed pore channels. The zeta potential analysis demonstrated that the grafting functional groups distributed on the inner and outer surfaces of On-Off-D-CMSN and On-Off-L-CMSN. Through dissolution experiment, the drug release of IMC loaded On-Off-D-CMSN (84%) and IMC loaded On-Off-L-CMSN (70%) were about 2.4 and 2.0 times higher than pure IMC (35%) in pH 6.8 phosphate buffer solution (PBS), respectively. IMC loaded On-Off-D-CMSN and IMC loaded On-Off-L-CMSN exerted different chiral recognition functions with On-Off mechanism in in-vitro chiral environment (pH 6.8 PBS-L and pH 6.8 PBS-D). The results of anti-inflammation pharmacodynamics further demonstrated that On-Off-D-CMSN and On-Off-L-CMSN can trigger chiral biological environment to achieve on or off chiral recognition functions. The unique advantages of On-Off chiral mesoporous silica nanoparticles in triggering chiral biological environment can provide valuable instruction for designing drug delivery system.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Supramolecular Self-Assembly in Materials · Drug Transport and Resistance Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Three-dimensional reconstruction of biological macromolecular complexes from in-lens scanning electron micrographs10.1111/j.1365-2818.2009.03168.x ↗
2. Understanding the growth of Eu2O3 nanocrystal films made via electrophoretic deposition10.1088/0957-4484/21/14/145704 ↗
3. Reconfigurable self-assembly through chiral control of interfacial tension10.1038/nature10769 ↗
4. Controlling supramolecular chirality of two-component hydrogels by J- and H-aggregation of building blocks10.1021/jacs.8b03309 ↗
5. Chirality of metal nanoparticles in chiral mesoporous silica10.1002/adfm.201200588 ↗
6. Concealed body mesoporous silica nanoparticles for orally delivering indometacin with chiral recognition function10.1016/j.msec.2018.04.071 ↗
7. Mesoporous silica nanoparticles in biomedical applications10.1039/c1cs15246g ↗
8. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging10.1016/j.colsurfb.2013.04.009 ↗
9. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug10.1016/j.ijpharm.2015.07.014 ↗
10. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals10.1002/smll.201000538 ↗
11. On the controllable soft-templating approach to mesoporous silicates
12. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study10.1016/j.ejpb.2011.12.002 ↗
13. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers10.1016/j.ejps.2015.02.008 ↗
14. Mesoporous silica formulation strategies for drug dissolution enhancement: a review10.1517/17425247.2016.1100165 ↗
15. Autofluorescent and pH-responsive mesoporous silica for cancer-targeted and controlled drug release10.1016/j.micromeso.2013.11.006 ↗
16. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release10.2147/IJN.S146955 ↗
17. Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers10.1002/adma.201001417 ↗
18. Light-operated mechanized nanoparticles10.1021/ja807798g ↗
19. Ultrasound-triggered smart drug release from a poly(dimethyl siloxane)–mesoporous silica composite10.1002/adma.200600387 ↗
20. Chiral mesoporous silica: chiral construction and imprinting via cooperative self-assembly of amphiphiles and silica precursors10.1039/C0CS00002G ↗
21. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells10.1016/j.actbio.2015.05.010 ↗
22. Understanding the mechanism of chirality transfer in the formation of a chiral MCM-41 mesoporous silica10.1021/jp1059825 ↗
23. Impact of cross-linking and drying method on drug delivery performance of casein-pectin microparticles10.1208/s12249-013-0012-8 ↗
24. Effect of complexes and microemulsions on the permeability of drugs: determination using a new biomimetic artificial membrane10.1208/s12249-018-1096-y ↗
25. The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity10.1016/j.ijpharm.2018.10.055 ↗
26. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica10.2147/IJN.S52605 ↗
27. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity10.1016/j.colsurfb.2016.02.009 ↗
28. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy10.1016/j.colsurfb.2017.11.006 ↗
29. Supramolecular chirality in organo-, hydro-, and metallogels derived from bis-amides of L-(+)-tartaric acid: formation of highly aligned 1D silica fibers and evidence of 5-c net SnS topology in a metallogel network10.1002/chem.201200871 ↗
30. Mesoporous silica nanoparticles functionalized with hyaluronic acid. Effect of the biopolymer chain length on cell internalization10.1016/j.colsurfb.2018.02.019 ↗
31. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers10.1016/j.addr.2008.03.012 ↗
32. Multimodal nanoporous silica nanoparticles functionalized with aminopropyl groups for improving loading and controlled release of doxorubicin hydrochloride10.1016/j.msec.2017.04.060 ↗
33. Clozapine-carboxylic acid plasticized co-amorphous dispersions: preparation, characterization and solution stability evaluation10.1515/acph-2015-0014 ↗
34. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan10.1016/j.jconrel.2010.04.029 ↗
35. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: superiority of amino modification10.1016/j.msec.2015.10.072 ↗
36. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug10.1016/j.jcis.2011.07.022 ↗
37. Impact of HPMC on inhibiting crystallization and improving permeability of curcumin amorphous solid dispersions10.1016/j.carbpol.2017.12.004 ↗